SparingVision selected for public presentation at the 10th Annual Biotech Showcase in San Francisco
The Foundation Fighting Blindness Clinical Research Institute (FFB-CRI), Bpifrance (Trough Biotechnology Accleration Fund & Innovative Biotherapies & Rare Diseases Fund set by the French national program « Investments for the future », and the Foundation Voir & Entendre (FVE) have invested in SparingVision: a total of € 15.5 million in SparingVIsion